Castañares, Flordeliza P.

HRN: 27-34-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/23/2025
08/24/2025
IV
500mg
Q8 X 3 Doses
S/p Lstcs
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines